‘I’ve been doing this for a long, long time. I think it’s a very rewarding thing to do.’ This episode of the Venari Podcast’s Talking Radiopharma series saw Matthew Palmer speak to Ariceum Therapeutics CEO Manfred Ruediger. A serial biotech entrepreneur, Manfred has worked in executive functions in biotech for almost 25 years. Ariceum’s development of novel targeted radiopharmaceuticals for cancer treatment – as well as Manfred’s considerable experience building out companies – certainly offered plenty of scope for discussion. Tune in to hear more about what Ariceum do differently, plus Manfred’s thoughts on team building and his advice for the radiopharmaceutical innovators of tomorrow! Our thanks to the Ariceum CEO and his team for this fascinating podcast. Listen on your favourite podcast platform here: https://lnkd.in/ehu3ZAxW #lifesciences #healthcare #radiopharma #insights #leadership
Venari Partners | Executive Search & Advisory Services’ Post
More Relevant Posts
-
🎧 Listen below! 🎧 Our CEO, Manfred Ruediger, appeared on The Venari Podcast by Venari Partners | Executive Search & Advisory Services! In the podcast, Manfred explores #Ariceum's approach to targeted #radiopharmaceuticals, highlighting the importance of having a highly specialised, talented team 🌟 🚀 Watch the full video below to discover more about Ariceum's journey and contribution to the #radiopharma field! Life Sciences & Healthcare | Venari Partners #lifesciences #biotech #radiopharmaceuticals #ATT001 #ATT002 #satoreotide
‘I’ve been doing this for a long, long time. I think it’s a very rewarding thing to do.’ This episode of the Venari Podcast’s Talking Radiopharma series saw Matthew Palmer speak to Ariceum Therapeutics CEO Manfred Ruediger. A serial biotech entrepreneur, Manfred has worked in executive functions in biotech for almost 25 years. Ariceum’s development of novel targeted radiopharmaceuticals for cancer treatment – as well as Manfred’s considerable experience building out companies – certainly offered plenty of scope for discussion. Tune in to hear more about what Ariceum do differently, plus Manfred’s thoughts on team building and his advice for the radiopharmaceutical innovators of tomorrow! Our thanks to the Ariceum CEO and his team for this fascinating podcast. Listen on your favourite podcast platform here: https://lnkd.in/ehu3ZAxW #lifesciences #healthcare #radiopharma #insights #leadership
-
🎙️ The BioHub Episode with Raphaël G. Ognar, MSc MBA is Live! 🎉 We’re thrilled to share our latest episode featuring Raphael Ognar, CEO of NKILT Therapeutics, Inc.🌟 In this episode, Raphael dives deep into his fascinating journey in biotech, shares insights on the cutting-edge immunotherapies being developed at NKILT, and talks about the future of cancer treatment. From overcoming challenges to leading innovation, this episode is packed with valuable lessons for anyone in biotech and beyond! 🚀 Tune in now! Links to the full episode are in the comments. 🔔 Don't forget to like, share, and subscribe to The BioHub Podcast for more incredible insights from biotech leaders! #TheBioHub #Podcast #Biotech #Immunotherapy #Leadership #RaphaelOgnar #NKILT #Innovation #CancerTreatment #FutureOfMedicine
-
-
TOLREMO therapeutics co-founder Stefanie Flückiger-Mangual discusses how she dealt with the death of her co-founder and mentor, Dr Wilhelm Krek. Check out our episode with Stefanie, available on our website and wherever you get your podcasts. - #swisspreneur #startup #entrepreneur #tolremo #cancer #cancerdrug #cancertreatment #biotech #medtech #podcast
-
Helping introverted scientists to speak up with confidence and become more visible without becoming overwhelmed.
I’m Louise and I help non-native introverted scientists in the Pharma and Biotech industry gain the confidence to be seen and heard so they can get the recognition they deserve and desire. Prices from 450€ for 3 sessions +MwSt DM me to arrange a discovery call to see how we might work together to achieve your goals. #pharma #oncology #impostersyndrome #podcast
-
-
Tune in to this week’s episode of Conversations Life Science Leaders Aren't Having. We welcomed Spiro Rombotis, the seasoned CEO of Cyclacel Pharmaceuticals, Inc. Spiro, with over two decades at Cyclacel and 37 years in the industry, shares his insights on the significant progress made in cancer treatment, fueled by advancements in genetics and the mapping of the human genome. This episode not only sheds light on the technical and ethical complexities of cancer research but also celebrates the human spirit's resilience and dedication to overcoming one of humanity's most daunting challenges. Listen in and here’s what you’ll learn about: - Evolution in Cancer Treatment Over 27 Years - Understanding Cancer at the Genetic Level - The Challenge of Failure in Drug Development - The Importance of Clinical Trial Participation - The Potential of Artificial Intelligence in Drug Development Conversations Life Science Leaders Aren't Having is LIVE today on Spotify, Apple Podcasts, and YouTube. Apple Podcasts: https://lnkd.in/ei6RY_hA Spotify: https://lnkd.in/e-DWW7vS Youtube: https://lnkd.in/ew4qTWez
-
-
Check out EP2 of Targeted Talks: Leaders in Oncology with the amazing Elisabeth Oelmann, MD, PhD We had fun making this episode! Apsida Life Science #TargetedTalksLeadersInOncology #oncology #clinicaldevelopment
Targeted Talks: Leaders in Oncology with Elisabeth Oelmann, MD, PhD Episode 2 is now live! Elisabeth sat down with Director, Jamie Salmon to discuss the secret to successfully managing a global remote team, what it's really like to move from big pharma to small biotech, and the life-changing event that inspired her career in medicine. Listen on Spotify | https://lnkd.in/eBHpT92k Watch on YouTube | https://lnkd.in/e4tpgrFU Read our Keytakeaways | https://lnkd.in/eRXika3n #apsidainsights #oncology #podcast #biotech #lifescience
-
-
🚀 Big news! Tomorrow we’re dropping an insightful episode with Kevin Warner, PharmD, SVP of Medical Affairs at Heron Therapeutics, Inc.! 🚀 In this episode, Kevin dives into Heron’s incredible milestones, and more importantly, why the work they’re doing is so crucial for the future of patient care. 🎙️ Here’s a sneak peek where Kevin explains why their innovations in pain management and oncology are making waves in the industry! Trust me, this is one you won’t want to miss. 🎧 🔔 Stay tuned for the full episode release tomorrow and be sure to like, share, and subscribe to The BioHub Podcast! #TheBioHub #Podcast #Biotech #Innovation #KevinWarner #HeronTherapeutics #FutureOfHealthcare #PainManagement #Oncology
-
This week on Podcast Cruzamento, we've talked with NUNO Prego Ramos. It was a fascinating discussion about #biotech, #innovation, #talent and #startup. Highlights: 🌟 Biotech Innovations: how CellmAbs developed groundbreaking cancer therapies, leading to a $1 billion deal with BioNTech SE 🌟 Digital Transformation: how AI and cutting-edge tech are making healthcare more effective and personalized. 🌟 Leadership & Vision: how Nuno is leveraging AI in oncology and age-related diseases with his new venture, Valvian. 🌟 Patient-Centric Strategies: how by focusing on patient outcomes and using targeted therapies and AI-driven data analysis, challenging diseases can be tackled and patient care improved. 🌟 Ecosystem and Talent: how to cultivate and retain Portuguese talent and the steps needed to make Portugal a global biotech hub. 🎧 https://lnkd.in/duiWZPEw (cc: Daniel Guedelha, Maria Loureiro, Hélder Romão, Beatriz Isabel Cruzeiro, Pedro Correa de Sampaio, Joana Pinto, Ana Catarina Gomes)
-
Enjoyed discussing #dei and it’s important to building successful companies with Matthew Pillar. Especially relevant in the context of #pride month and #junteenth Diversity has and continues to be the foundation of our success at Arcellx Take a listen and let me know what you think
Our Chairman and CEO, Rami Elghandour, recently sat down with Matthew Pillar of Business of Biotech podcast to discuss entrepreneurship and the importance of #DEI to creating exceptional teams that deliver outstanding performance, starting in the #CSuite. Listen here: https://lnkd.in/eVtEycJ3 #oncologynews #biotech #oncology #multiplemyeloma #science
-
-
Season 2 | Ep 4 - Kelly O'Hare on defining and articulating the value of quality to your organisation.🚀 Kelly O'Hare, current Vice President, Head of Quality at enGene, an innovative biotech developing a non-viral gene therapy focussed on the treatment of bladder cancer, joins Hemish Ilangaratne on todays episode! Kelly shares her journey in quality, discussing her transition from a technical writer to a quality leader. We talk about the importance of quality leaders being able to articulate the value of quality to their organizations. Her insights provide valuable lessons for aspiring quality professionals and leaders. Chapters 🎤00:00 Introduction to Quality and Career Journey. 🎤02:55 Transitioning from Science to Quality Leadership. 🎤06:03 Building Confidence in Quality Decisions. 🎤08:52 Defining and Articulating Quality. 🎤11:59 The Importance of Quality Management Systems. 🎤14:58 User Feedback and Quality System Implementation. 🎤17:59 Evolving Perceptions of Quality in Organizations. 🎤20:55 Inspiring Passion for Quality in Teams. 🎤23:50 Legacy and Mentorship in Quality Leadership. 🎤27:02 Final Thoughts and Advice for Future Leaders. This is a great conversation about why and how to define and articulate quality and the benefits this can bring to your career, your organisation, and the patient populations you serve. A huge thank you to Kelly for joining us on the show and sharing her journey. Episode available now on Apple and Spotify⬇ We hope you enjoy the show!🔥
-
